Claiborne Cary J 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed May 25, 2023
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-05-23+300,000→ 300,000 totalExercise: $0.30From: 2023-05-23Exp: 2033-05-23→ Common Stock (300,000 underlying) - Award
Common Stock
2023-05-23+420,000→ 1,520,000 total
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.